Evidence map›Paper›PMID 40158620›Full record

ArticleJournal of advanced research2026

Prediction of influenza virus infection based on deep learning and peripheral blood proteomics: A diagnostic study.

Yumei Zhou, Pengbo Wang, Haiyun Zhang, Taihao Wang, Shuai Han, Xin Ma, Shuang Liang, Minghua Bai, Pengbei Fan, Lei Wang and 2 more

Abstract read
In one paragraph

Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yumei ZhouNational Institute of TCM Constitution and Preventive Treatment of Disease, Wangqi Academy of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China.
Pengbo WangXinxiang Medical University, Xinxiang, Henan 453003, PR China.
Haiyun ZhangNational Institute of TCM Constitution and Preventive Treatment of Disease, Wangqi Academy of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China; Medical Laboratory Center, Dalian Municipal Women and Children's Medical Center (Group), Dalian, Liaoning 116033, PR China.
Taihao WangCapital Medical University, Beijing 100069, PR China.
Shuai HanInner Mongolia Medical University, Hohhot, Inner Mongolia 010070, PR China.
Xin MaChina Railway Construction Corporation, Beijing Tiejian Hospital, Beijing 100039, PR China.
Shuang LiangDepartment of Radiology, The Second Affiliated Hospital to Mudanjiang Medical University, Mudanjiang, Heilongjiang 157000, PR China.
Minghua BaiNational Institute of TCM Constitution and Preventive Treatment of Disease, Wangqi Academy of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China.
Pengbei FanNational Institute of TCM Constitution and Preventive Treatment of Disease, Wangqi Academy of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China.
Lei WangHubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, PR China. Electronic address: lncyly@126.com.
Ji WangNational Institute of TCM Constitution and Preventive Treatment of Disease, Wangqi Academy of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China; Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, PR China. Electronic address: doctorwang2009@126.com.
Qi WangNational Institute of TCM Constitution and Preventive Treatment of Disease, Wangqi Academy of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China; Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInfluenza viruses cause seasonal epidemics almost every year, and it is difficult to diagnose quickly and accurately. Machine learning and peripheral blood protein omics have brought new ideas to the research of clinical markers.

objectivesPrediction of key molecular marker of influenza virus infection by the established machine learning model and peripheral blood protein omics.

methodsThis study used the testing data of 850 patients (including influenza, COVID-19 and mixed infections) and 265 healthy individuals, to establish and validate a diagnostic prediction model for influenza infection and verified the potential value of this model in the differential diagnosis of influenza, COVID-19 and healthy people.

resultsThe overall analysis showed that there were significant differences in 9 clinical features in the influenza group. Principal component analysis can effectively group samples based on these clinical features. Based on the random forest model and LASSO regression model found that the selected features are clinical indicators that can accurately distinguish influenza patients. We performed proteome sequencing combined with machine learning and found a total of 26 DEPs. Through PPI and WGCNA analysis, we identified several genes related to the proportion of monocytes. We then analyzed the correlation of these factors with immune cell proportions and found that SAA1 and SAA2 were highly correlated with various vital immunocyte. ROC curve analysis shows that SERPINA3 can distinguish influenza, COVID-19, mixed infection and healthy people; SAA1 can distinguish COVID-19, mixed infection and healthy people; SAA2 can distinguish influenza and healthy people. In influenza, high expression of SERPINA3, SAA1, and SAA2 is associated with higher risk. Finally, we used the ELISA method to confirm that SAA2 protein can be used as an auxiliary diagnostic indicator for influenza infection.

conclusionsPreliminary results showed that SAA2 is an important molecular marker specific to influenza infection.

Indexed as

Deep LearningInfluenza A virusInfluenza, HumanProteomeProteomicsBiomarkersCase-Control StudiesCOVID-19Diagnosis, DifferentialEnzyme-Linked Immunosorbent AssayGene Regulatory NetworksHumansKaplan-Meier EstimatePredictive Value of TestsPrincipal Component AnalysisProportional Hazards ModelsBiomarkersProteomeSAA1 protein, humanSAA2 protein, humanSERPINA3 protein, humanSerpinsSerum Amyloid A ProteinCOVID-19Deep learningInfluenzaProteomicsSAA2

Identifiers

PMID40158620
PMCPMC12766177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.